ARDX vs. OLMA
ARDX (Ardelyx, Inc.) and OLMA (Olema Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, ARDX returned -4.29%/yr vs -17.63%/yr for OLMA. At a 0.26 correlation, their price movements are largely independent.
Performance
ARDX vs. OLMA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARDX achieves a -7.03% return, which is significantly higher than OLMA's -57.96% return.
ARDX
- 1D
- -1.81%
- 1M
- -25.75%
- YTD
- -7.03%
- 6M
- -6.07%
- 1Y
- 37.91%
- 3Y*
- 15.47%
- 5Y*
- -4.29%
- 10Y*
- -4.98%
OLMA
- 1D
- -1.68%
- 1M
- -28.16%
- YTD
- -57.96%
- 6M
- -61.43%
- 1Y
- 159.51%
- 3Y*
- 22.84%
- 5Y*
- -17.63%
- 10Y*
- —
ARDX vs. OLMA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
ARDX Ardelyx, Inc. | -7.03% | 14.99% | -18.23% | 117.54% | 159.09% | -83.00% | 13.31% |
OLMA Olema Pharmaceuticals, Inc. | -57.96% | 328.82% | -58.45% | 472.65% | -73.82% | -80.53% | -1.88% |
Correlation
The correlation between ARDX and OLMA is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Nov 20, 2020 | 0.26 |
Fundamentals
ARDX:
$1.33B
OLMA:
$1.08B
ARDX:
-$0.24
OLMA:
-$2.03
ARDX:
8.97
OLMA:
2.25
ARDX:
$427.68M
OLMA:
$0.00
ARDX:
$395.63M
OLMA:
-$187.00K
ARDX:
-$28.55M
OLMA:
-$197.79M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARDX vs. OLMA — Risk / Return Rank
ARDX
OLMA
ARDX vs. OLMA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ardelyx, Inc. (ARDX) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ARDX | OLMA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.38 | ||
| Sortino ratioReturn per unit of downside risk | -1.93 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.43 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | 1.14 | 2.27 | -1.14 |
| Martin ratioReturn relative to average drawdown | 2.36 | 4.83 | -2.47 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ARDX | OLMA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.62 | 1.00 | -0.38 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | -0.16 | +0.12 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.06 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.09 | -0.23 | +0.14 |
Drawdowns
ARDX vs. OLMA - Drawdown Comparison
The maximum ARDX drawdown since its inception was -98.45%, roughly equal to the maximum OLMA drawdown of -96.26%. Use the drawdown chart below to compare losses from any high point for ARDX and OLMA.
Loading charts...
Drawdown Indicators
| ARDX | OLMA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.45% | -96.26% | -2.19% |
Max Drawdown (1Y)Largest decline over 1 year | -33.54% | -70.67% | +37.13% |
Max Drawdown (3Y)Largest decline over 3 years | -66.32% | -82.15% | +15.83% |
Max Drawdown (5Y)Largest decline over 5 years | -93.76% | -93.36% | -0.40% |
Max Drawdown (10Y)Largest decline over 10 years | -96.82% | — | — |
Current DrawdownCurrent decline from peak | -83.52% | -80.72% | -2.80% |
Average DrawdownAverage peak-to-trough decline | -77.37% | -74.98% | -2.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.21% | 33.14% | -16.93% |
Volatility
ARDX vs. OLMA - Volatility Comparison
The current volatility for Ardelyx, Inc. (ARDX) is 10.38%, while Olema Pharmaceuticals, Inc. (OLMA) has a volatility of 21.66%. This indicates that ARDX experiences smaller price fluctuations and is considered to be less risky than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARDX | OLMA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.38% | 21.66% | -11.28% |
Volatility (6M)Calculated over the trailing 6-month period | 46.48% | 55.93% | -9.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.47% | 160.52% | -99.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 89.42% | 107.97% | -18.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.09% | 106.41% | -22.32% |
Dividends
ARDX vs. OLMA - Dividend Comparison
Neither ARDX nor OLMA has paid dividends to shareholders.
Financials
ARDX vs. OLMA - Financials Comparison
This section allows you to compare key financial metrics between Ardelyx, Inc. and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ARDX and OLMA have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OLMA has higher volatility (21.66%) compared to ARDX (10.38%). In terms of maximum drawdown, ARDX dropped -98.45% vs OLMA's -96.26%.
OLMA currently has the higher Sharpe Ratio (1.00 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARDX and OLMA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer